Mold-tek Technologies
Standalone Q2 PAT more than tripled to ₹10.16 Cr on ₹46.64 Cr sales. Consolidated H1 PAT of ₹18.62 Cr trails standalone ₹20.19 Cr due to Beryl subsidiary losses. Management hedges on Beryl breakeven and acquisition…
ALFA Concalls
Every earnings call, live and summarised
Earnings calls
Every Mold-tek Technologies earnings call we streamed: the live audio and our summary of what management said.
Standalone Q2 PAT more than tripled to ₹10.16 Cr on ₹46.64 Cr sales. Consolidated H1 PAT of ₹18.62 Cr trails standalone ₹20.19 Cr due to Beryl subsidiary losses. Management hedges on Beryl breakeven and acquisition…
Standalone Q2 PAT more than tripled to ₹10.16 Cr on ₹46.64 Cr sales. Consolidated H1 PAT of ₹18.62 Cr trails standalone ₹20.19 Cr due to Beryl subsidiary losses. Management hedges on Beryl breakeven and acquisition plans.
Guides 18-20% consolidated and about 20-25% standalone top-line growth over 12-18 months, subject to USD moves. No FY28 numbers given.
Mold-Tek delivered a stellar Q1 FY27 with a 12x YoY profit jump, driven by aggressive cost-cutting in the weak MES division and strong traction in US civil engineering and data center power distribution.
Mold-Tek Technologies reported a Q4FY26 turnaround with PAT of ₹2.28cr vs a loss of ₹1.6cr YoY, despite ₹4cr MTM forex losses. Focus shifting to high-margin structural design and the Beryl acquisition.
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.